Atlas Trials

Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis

Clinical trial NCT00003368 · COMPLETED

Trial details

NCT number
NCT00003368
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Start date
1998-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.